<DOC>
	<DOCNO>NCT01855945</DOCNO>
	<brief_summary>Evaluate safety immunogenicity three dosage level swine influenza vaccine child age 3 &lt; 9 year , adolescent 9 &lt; 18 year , adult 18 &lt; 65 year elderly 65 year old .</brief_summary>
	<brief_title>Safety Immunogenicity Three Dosage Levels Swine Influenza Vaccine Children Ages 3 &lt; 9 Years , Adolescents 9 &lt; 18 Years , Adults 18 &lt; 65 Years Elderly 65 Years Older .</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Males females 3 year age old 2 . Individuals , ( child adolescent ) parent legal guardian , give write consent nature study explain accord local regulatory requirement . Assent require depending age child/adolescent 3 . Individuals good health determine outcome medical history , physical examination , clinical judgment investigator 4 . Individuals comply study procedure available followup 1 . Individuals behavioral cognitive impairment , include psychiatric illness , determine investigator 's clinical judgement may interfere subject 's ability participate study 2 . Individuals progressive severe neurologic disorder , seizure disorder recent history GuillianBarré syndrome 3 . Individuals ( child adolescent ) parent legal guardian able comprehend follow require study procedure whole period study 4 . Individuals history illness/with ongoing illness , opinion investigator , may pose additional risk subject he/she participate study 5 . Individuals suspected/confirmed diagnosis Adverse event Special interest 6 . Individuals know suspected impairment immune system include , limited : autoimmune disease rheumatoid arthritis , HIV infection , hypo agammaglobulinemia ; autoimmune disorder ; Systemic therapy corticosteroid immunosuppressive therapy . Receipt immunoglobulin preparation , blood product , and/or plasma derivative within 3 month prior Day 1 plan full length study 7 . Individuals pregnant breastfeeding . Female subject childbearing potential must negative pregnancy test prior study vaccine administer 8 . If female , `` childbearing potential '' , sexually active , use `` acceptable contraceptive method '' least 2 month prior study entry 9 . `` Of childbearing potential '' define status post onset menarche meeting follow condition : menopausal least 2 year , status bilateral tubal ligation least 1 year , status bilateral oophorectomy , status hysterectomy 10 . Acceptable birth control method define one following : 1 . Hormonal contraceptive ( oral , injection , transdermal patch , implant , cervical ring ) ; 2 . Barrier ( condom spermicide diaphragm spermicide ) every time intercourse ; 3 . Intrauterine device ( IUD ) ; 4 . Monogamous relationship vasectomize partner . Partner must vasectomize least six month prior subject 's study entry . 11 . If female childbearing potential sexually active , refusal use `` acceptable contraceptive method '' 3 week last study vaccination 12 . Individuals allergic vaccine component . 13 . For child 17 year age younger : Individuals ever malignancy 14 . For adults 18 year old : Individuals malignancy ( exclude nonmelanotic skin cancer ) lymphoproliferative disorder within past 5 year 15 . Individuals participate clinical trial another investigational product 30 day prior first study visit intent participate another clinical study time conduct study 16 . Individuals body temperature &gt; 38°C ( &gt; 100.4°F ) acute illness within 3 day intend study vaccination 17 . Individuals previous confirm suspected illness swine flu ( H3N2v ) 18 . Individuals receive prior H3N2v vaccine 19 . Individuals receive type influenza vaccination ( e.g. , `` seasonal '' ) within 14 day prior enrolment , plan receive influenza vaccine treatment phase study ( seasonal influenza vaccination allow Day 43/Visit 3 ) 20 . Individuals receive licensed vaccine within 2 week ( inactivated vaccine ) 4 week ( live vaccine ) prior enrolment study plan receive ( noninfluenza ) vaccine within 4 week study vaccine 21 . Individuals research staff involve clinical study family/household member research staff 22 . Individuals BMI &gt; 35 kg/m2 ( adult ) , &gt; 29 kg/m2 ( adolescent ) , &gt; 21 kg/m2 ( child ) 23 . Individuals history drug alcohol abuse within past 2 year</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>92 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Influenza</keyword>
</DOC>